Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their high cost limits ...

On October 25, 2025, scientists revealed a groundbreaking discovery of a hidden gene mutation that causes deafness, shedding ...

This granted U.S. patent represents an important milestone for JayaBio,” said Pawel Krysiak, President and Chief Executive Officer of Jaya Biosciences. “It underscores our commitment to addressing the ...

Scientists at The University of Texas at Austin have developed a revolutionary gene-editing method using bacterial retrons ...

ImmunoAct, backed by government funding, is advancing CAR-T cell therapy to make cancer treatment more accessible. Their product, NexCAR19, uses patients' immune systems to fight cancer. With support ...

An increasing demand for gene therapies is focusing the industry on enhancing production capabilities, transitioning from ...

Around the globe, heart disease remains one of the top causes of death. Once patients begin to suffer from serious heart ...

The government has extended financial support to ImmunoAct to expand gene delivery systems, making breakthrough cancer treatments more affordable. Clinical trials of CAR-T therapy have been promising ...

In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...

Adeno-associated virus (AAV) gene therapies hold great promise, but ensuring product quality is critical. One major challenge? The presence of empty capsids, which can reduce therapeutic effectiveness ...

Scientists looked at multiple techniques used to measure the modified viruses deployed in some gene therapy research and treatments. One technique, known as SEC-MALS, was the most precise and accurate ...